RLAY

NASDAQStock$18.32-0.13 (-0.70%)
Mkt Cap 4.0BP/E —Div Yield —Beta 1.73Vol 970.4K
52W$6.05
$20.75

ETFs That Hold RLAY (Relay Therapeutics, Inc.)

1M

-4.86%

3M

-0.16%

6M

+23.14%

YTD

+125.06%

1Y

+184.10%

3Y

+186.76%

5Y

-40.50%

ETFs That Hold RLAY

Relay Therapeutics, Inc. is held by 97 ETFs. The largest position by market value is in XBI (State Street SPDR S&P Biotech ETF).

ETFFund NameWeight
XBIState Street SPDR S&P Biotech ETF0.86%
IWMiShares Russell 2000 ETF0.11%
IWOiShares Russell 2000 Growth ETF0.17%
IBBiShares Biotechnology ETF0.21%
DFASDimensional - US Small Cap ETF0.06%
TCAFT. Rowe Capital Appreciation Equity ETF0.19%
SCHASchwab U.S. Small-Cap ETF0.07%
DFACDimensional - US Core Equity 2 ETF0.01%
FESMFidelity Enhanced Small Cap ETF0.14%
DFMCU.S. Micro Cap Portfolio ETF0.12%
VHTVanguard Health Care ETF0.03%
PTHInvesco Dorsey Wright Healthcare Momentum ETF2.11%
SBIOALPS Medical Breakthroughs ETF2.66%
VFMOVanguard U.S. Momentum Factor ETF0.22%
PRFZInvesco RAFI US 1500 Small-Mid ETF0.15%
CANCTema Oncology ETF1.92%
TMSLT. Rowe Price Small-Mid Cap ETF0.12%
DWASInvesco Dorsey Wright SmallCap Momentum ETF0.90%
USVMVictoryShares US Small Mid Cap Value Momentum ETF0.19%
DCORU.S. Core Equity 1 Portfolio ETF Class Shares0.01%

Excludes leveraged and inverse ETFs.

Page 1 of 5Next

Frequently Asked Questions

How many ETFs hold RLAY?
Relay Therapeutics, Inc. (RLAY) is held by 97 ETFs (excluding leveraged and inverse funds). The largest position by market value is in XBI (State Street SPDR S&P Biotech ETF).
What is the largest ETF that holds RLAY?
By fund size, XBI (State Street SPDR S&P Biotech ETF) with $10.07B in AUM holds 0.86% of its portfolio in RLAY, representing $86.7M in market value.
What percentage of SBIO is RLAY?
RLAY makes up 2.66% of SBIO (ALPS Medical Breakthroughs ETF), making it one of the largest positions in that fund.
Is RLAY in the S&P 500?
RLAY is not currently a component of the S&P 500 index based on available ETF holdings data.
FREE DOWNLOAD

The Beginner's Guide to ETFs

20 pages. Zero fluff. Everything you need to start investing in ETFs.

No spam. Unsubscribe anytime.